Condition
Lung Squamous Cell Carcinoma clinical trials and research
As of November 12, 2026, Find a Trial lists 6 Lung Squamous Cell Carcinoma clinical trials that are recruiting, at sites in 15 countries (most in China (5), Spain (2), United States (2)). By phase: Phase 1/2 (2), Phase 2 (1), Phase 1 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 6Clinical trials
- 15Countries
Newest Lung Squamous Cell Carcinoma clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| JMT106 injection for advanced solid tumors | Phase 1 | Zhejiang | Recruiting | Dec 10, 2025 |
| TER-2013 for advanced solid tumors with AKT/PI3K/PTEN pathway changes | Phase 1/2 | Duarte, California and 24 other locations | Recruiting | Aug 7, 2025 |
| Observational study on characteristics and outcomes of patients with surgically removed lung cancers | — | Beijing, Beijing Municipality | Recruiting | Feb 13, 2024 |
| Combining low-dose radiation with immunotherapy and chemotherapy for lung cancer treatment | Phase 2 | Chongqing, Chongqing Municipality and 5 other locations | Recruiting | Nov 8, 2023 |
| Testing AZD5335 for advanced solid tumors | Phase 1/2 | Duarte, California and 59 other locations | Recruiting | Apr 4, 2023 |
| Using ctDNA testing and AI to improve treatment predictions for lung cancer | — | Changsha, Hunan | Recruiting | Mar 21, 2023 |
All recruiting trials (6)
-
JMT106 injection for advanced solid tumors
This first-in-human Phase 1 trial will try JMT106 injection as a single treatment for adults with advanced solid tumors who have exhausted or do not have standard therapy options.
-
TER-2013 for advanced solid tumors with AKT/PI3K/PTEN pathway changes
This trial tests whether TER-2013, alone or with fulvestrant, is safe and can help people with advanced breast, ovarian, endometrial, lung, or head-and-neck cancers that have AKT/PI3K/PTEN pathway alterations.
-
Observational study on characteristics and outcomes of patients with surgically removed lung cancers
This study looks at patients in China who have had lung cancer surgery to see how their treatment and outcomes vary and what factors might affect their survival.
-
Combining low-dose radiation with immunotherapy and chemotherapy for lung cancer treatment
This study is testing if adding low-dose radiation to standard chemotherapy and a new immune treatment can help people with advanced lung cancer feel better and live longer.
-
Testing AZD5335 for advanced solid tumors
This study is testing a new treatment called AZD5335, alone or with other cancer drugs, to see if it helps people with advanced ovarian cancer and lung adenocarcinoma.
-
Using ctDNA testing and AI to improve treatment predictions for lung cancer
This study is testing if using blood tests for tumor DNA along with AI can help doctors better predict how well a new treatment works for patients with lung cancer that can be surgically removed.
Related topics
Quick answers
How many Lung Squamous Cell Carcinoma clinical trials are recruiting right now?
6, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 15 countries. The most sites are in China (5 trials), Spain (2 trials), United States (2 trials), Australia (1 trial), Canada (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 1/2: 2, Phase 2: 1, Phase 1: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.